REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medipharma S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Medipharma S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Medipharma S.A. is an enterprise in Ecuador, with the main office in Quito. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on August 27, 2015. Medipharma S.A. currently employs 5 (2023) people. In 2023, the company reported a net sales revenue increase of 44.97%. Its’ total assets recorded a growth of 51.22%. The net profit margin of Medipharma S.A. decreased by 2.15% in 2023.

Headquarters
N52 Antonio Roman N51151, Andromeda Bldg. , Floor 1
Quito; Pichincha;

Contact Details: Purchase the Medipharma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Medipharma S.A. report to view the information.
Outstanding Shares:
Purchase the Medipharma S.A. report to view the information.
Registered Capital:
Purchase the Medipharma S.A. report to view the information.
Incorporation Date:
August 27, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
40%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Medipharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
44.97%▲
Total operating revenue
44.97%▲
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-85.33%▼
Total assets
51.22%▲
Total equity
15.65%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-2.15%▼
Return on Equity (ROE)
-45.14%▼
Quick Ratio
-0.3%▼
Cash Ratio
-0.21%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo